Document is current

Any future updates will be listed below

Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy

Crossref DOI link: https://doi.org/10.1007/s12288-016-0647-1

Published Online: 2016-01-27

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark